Skip to main content
. 2023 Apr 7;13:5748. doi: 10.1038/s41598-023-32957-y

Table 1.

Demographic data of enrolled patients.

IDH1-wt IDH1-R132H Value (P) Difference (95% CI) Total
Age at diagnosis, mean (SD) 55.58 ± 17.77 44.2 ± 12. 18 Z = − 2.90 (0.004) 16 (9–23) 48.98 ± 14.37
Sex, n (%) Χ2 = 0.036 (0.851) 0.025 (− 0.219 to 0.266)
 Male 11 (50) 19 (47.5) 30 (48.4)
 Female 11 (50) 21 (52.5) 32 (51.6)
Location, n (%) * Χc2 = 15.07 (0.005)
 Frontal lobe 7 (31.8) 32 (80.0) Χ2 = 14.12 (< 0.001) 0.482 (0.226 to 0.663) 39 (62.9)
 Temporal lobe 10 (45.5) 5 (12.5) Χ2 = 8.405(0.004) 0.330 (0.100 to 0.541) 15 (24.2)
 Parietal lobe 2 (9.1) 2 (5.0) – (0.61) 0.041c (− 0.111 to 0.260) 4 (6.5)
 Occipital lobe 1 (4.5) 0 (0.0) – (0.36) 0.046c (− 0.072 to 0.249) 1 (1.6)
 Insular lobe 2 (9.1) 1 (9.1) – (0.28) 0.066c (− 0.078 to 0.284) 3 (4.8)
Χc2 = 0.026 (0.987)
Left cerebral hemisphere 9 (40.9) 17 (42.5) Χ2 = 0.015 (0.903) 0.016 (− 0.231 to 0.250) 26 (41.9)
Right cerebral hemisphere 12 (54.5) 21 (52.5) Χ2 = 0.024 (0.877) 0.021 (− 0.226 to 0.259) 33 (53.2)
Both right and left cerebral hemisphere 1 (4.5) 2 (5.0) – (1.00) 0.005c (− 0.20 to 0.14) 3 (4.8)
Histopathology, n (%) Χc2 = 14.12 (< 0.001)
 Oligodendroglioma 2 (9.1) 26 (65.0) Χ2 = 17.914 (< 0.001) 0.559 (0.316 to 0.704) 28 (45.2)
 Astrocytoma 2 (9.1) 7 (17.5) Χc2 = 0.273 (0.601) 0.084c (− 0.152 to 0.260) 9 (14.5)
 Glioblastoma 18 (81.8) 6 (15.0) Χ2 = 26.710 (< 0.001) 0.668 (0.421 to 0.803) 24 (38.7)
 Not classification 0 (0.0) 1 (2.5) – (1.00) 0.025c (− 0.162 to 0.147) 1 (1.6)
WHO classification, n (%) – (< 0.001)
 Grade 2 0 (0.0) 11 (27.5) – (0.005) 0.275c (0.053 to 0.441) 11 (17.7)
 Grade 3 4 (18.2) 23 (57.5) Χ2 = 8.925 (0.003) 0.393 (0.139 to 0.570) 27 (43.5)
 Grade 4 18 (81.8) 6 (15.0) Χ2 = 26.71 (< 0.001) 0.668 (0.421 to 0.803) 24 (38.7)
IDH1-wt IDH1-R132H Value (P) Difference (95% CI) Total
Age at diagnosis, mean (SD) 54.96 ± 11.26 44 ± 10.48 Z = − 3.26 (0.001) 14 (7–19) 50.43 ± 12.13
Sex, n (%) Χ2 = 0.199 (0.766) 0.066 (− 0.207 to 0.331)
 Male 16 (59.3) 10 (52.6) 26 (56.5)
 Female 11 (40.7) 9 (47.4) 20 (43.5)
Location, n (%) * – (0.002)
 Frontal lobe 8 (29.6) 11 (57.9) Χ2 = 3.675 (0.073) 0.283 (− 0.004 to 0.517) 19 (41.3)
 Temporal lobe 11 (40.7) 1 (5.3) Χc2 = 5.556 (0.018) 0.355c (0.066 to 0.563) 12 (26.1)
 Parietal lobe 3 (11.1) 3 (15.8) Χc2 = 0.000 (0,985) 0.047c (− 0.178 to 0.307) 6 (13.0)
 Occipital lobe 3 (11.1) 0 (0.0) – (0.257) 0.111c (− 0.114 to 0.303) 3 (6.5)
 Insular lobe 0 (0.0) 4 (21.1) – (0.024) 0.211c (0.033 to 0.433) 4 (8.7)
 Others 2 (7.4) 0 (0.0) – (0.504) 0.074c (− 0.144 to 0.258) 2 (4.3)
– (0.286)
Left cerebral hemisphere 11 (40.7) 12 (63.2) Χ2 = 2.242 (0.231) 0.224 (− 0.064 to 0.464) 23 (50.0)
Right cerebral hemisphere 15 (55.6) 7 (36.8) Χ2 = 1.565 (0.245) 0.187 (− 0.100 to 0.432) 22 (47.8)
Both right and left cerebral hemisphere 1 (3.7) 0 (0.0) – (1.000) 0.037c (− 0.175 to 0.209) 1 (2.2)
Histopathology, n (%) – (< 0.001)
 Oligodendroglioma 2 (7.4) 9 (47.4) Χc2 = 7.715 (0.005) 0.400c (0.112 to 0.639) 11 (23.9)
 Astrocytoma 2 (7.4) 9 (47.4) Χc2 = 7.715 (0.005) 0.400c (0.112 to 0.639) 11 (23.9)
 Glioblastoma 20 (74.1) 0 (0.0) – (< 0.001) 0.741c (0.489 to 0.868) 20 (43.5)
 Not classification 3 (11.1) 1 (5.3) Χc2 = 0.026 (0.872) 0.059c (− 0.184 to 0.257) 4 (8.7)
WHO classification, n (%) Χc2 = 15.557 (0.001)
 Grade 2 4 (14.8) 8 (42.1) Χc2 = 3.009 (0.083) 0.273c (− 0.016 to 0.532) 12 (26.1)
 Grade 3 2 (7.4) 7 (36.8) Χc2 = 4.412 (0.036) 0.294c (0.026 to 0.547) 9 (19.6)
 Grade 4 21 (77.8) 4 (21.0) Χ2 = 14.463 (< 0.001) 0.567 (0.277 to 0.738) 25 (54.3)

Significant values are in bold.